UA94464C2 - Isolated anti-dll4 antibody and methods using same - Google Patents

Isolated anti-dll4 antibody and methods using same

Info

Publication number
UA94464C2
UA94464C2 UAA200900120A UAA200900120A UA94464C2 UA 94464 C2 UA94464 C2 UA 94464C2 UA A200900120 A UAA200900120 A UA A200900120A UA A200900120 A UAA200900120 A UA A200900120A UA 94464 C2 UA94464 C2 UA 94464C2
Authority
UA
Ukraine
Prior art keywords
isolated anti
methods
same
dll4 antibody
antibody
Prior art date
Application number
UAA200900120A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Минхонг Янь
Ян Ву
Original Assignee
Дженентек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дженентек, Инк. filed Critical Дженентек, Инк.
Publication of UA94464C2 publication Critical patent/UA94464C2/en

Links

Abstract

The invention relates to an isolated anti-DLL4 antibody, a polynucleotide encoding thereof, a vector, host cell, a method for producing the antibody and composition comprising thereof. The invention further relates to a method for diagnosing a disorder associated with DLL4 expression, a method for treating a tumor, cancer, or cell proliferative disorder and a method of enhancing efficacy of an anti-angiogenic agent in a subject.
UAA200900120A 2006-06-06 2007-06-06 Isolated anti-dll4 antibody and methods using same UA94464C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81135706P 2006-06-06 2006-06-06

Publications (1)

Publication Number Publication Date
UA94464C2 true UA94464C2 (en) 2011-05-10

Family

ID=40891998

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200900120A UA94464C2 (en) 2006-06-06 2007-06-06 Isolated anti-dll4 antibody and methods using same

Country Status (2)

Country Link
CN (1) CN101489576A (en)
UA (1) UA94464C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130078247A1 (en) * 2011-04-01 2013-03-28 Boehringer Ingelheim International Gmbh Bispecific binding molecules binding to dii4 and ang2

Also Published As

Publication number Publication date
CN101489576A (en) 2009-07-22

Similar Documents

Publication Publication Date Title
UA95068C2 (en) Antigen binding molecules that bind egfr, vectors encoding same, and uses thereof
MX2009009787A (en) K-ras mutations and anti-egfr antibody therapy.
MX2010000537A (en) Monoclonal antibodies against glypican-3.
WO2016059602A3 (en) Combination therapy with anti-her3 antibodies to treat cancer
MX2012010128A (en) Therapeutic dll4 binding proteins.
MX346924B (en) Diarylhydantoin compounds.
MX2011009220A (en) Fully human antibodies specific to cadm1.
MX2009009779A (en) K-ras and b-raf mutations and anti-egfr antibody therapy.
BRPI0611670A2 (en) method for treating or preventing cancer in an individual
MX2013002535A (en) Novel antigen binding proteins.
BRPI0918555A2 (en) antibody, composition, nucleic acid molecule, method of treating a malignant tumor in an animal, and, use of the composition.
IL184617A0 (en) Dr5 antibodies and uses thereof
WO2009120903A3 (en) Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof
UA94707C2 (en) Antigen-binding molecule capable of binding to plgf
WO2009150470A3 (en) Suppression of cancers
MX356866B (en) P53 biomarkers.
TN2011000524A1 (en) Antibodies specific to cadherin -17
WO2008011519A3 (en) Amigo-2 inhibitors for treating, diagnosing or detecting cancer
MX2009005058A (en) Methods of treating, diagnosing or detecting cancer.
WO2009074968A3 (en) Method for predicting the efficacy of cancer therapy
MA32288B1 (en) New antibodies useful for cancer treatment
TNSN08401A1 (en) Methods of treating diagnosing or detecting cancer
WO2007033167A3 (en) Compositions and methods for detecting and treating cancer
MX2016001439A (en) Compositions and methods for identifying a risk of cancer in a subject.
WO2010099139A3 (en) Combination of an either an anti-igf-ir- antibody or an igf binding protein and a small molecule igf-ir kinease inhibitor